- Home
- NSPR vs WHWK Comparison
NSPR vs WHWK Comparison
Compare NSPR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- WHWK
- Stock Information
- Founded
- NSPR 2005
- WHWK 2007
- Country
- NSPR United States
- WHWK United States
- Employees
- NSPR N/A
- WHWK N/A
- Industry
- NSPR Medical/Dental Instruments
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- NSPR Health Care
- WHWK Health Care
- Exchange
- NSPR Nasdaq
- WHWK Nasdaq
- Market Cap
- NSPR 101.8M
- WHWK 82.4M
- IPO Year
- NSPR N/A
- WHWK N/A
- Fundamental
- Price
- NSPR $2.38
- WHWK $1.99
- Analyst Decision
- NSPR Strong Buy
- WHWK
- Analyst Count
- NSPR 2
- WHWK 0
- Target Price
- NSPR $4.50
- WHWK N/A
- AVG Volume (30 Days)
- NSPR 79.2K
- WHWK 127.2K
- Earning Date
- NSPR 11-11-2025
- WHWK 08-07-2025
- Dividend Yield
- NSPR N/A
- WHWK N/A
- EPS Growth
- NSPR N/A
- WHWK N/A
- EPS
- NSPR N/A
- WHWK N/A
- Revenue
- NSPR $7,066,000.00
- WHWK $21,596,000.00
- Revenue This Year
- NSPR $7.48
- WHWK N/A
- Revenue Next Year
- NSPR $104.39
- WHWK N/A
- P/E Ratio
- NSPR N/A
- WHWK N/A
- Revenue Growth
- NSPR 7.60
- WHWK N/A
- 52 Week Low
- NSPR $1.99
- WHWK $1.39
- 52 Week High
- NSPR $3.80
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- NSPR 44.77
- WHWK 66.97
- Support Level
- NSPR $2.35
- WHWK $1.78
- Resistance Level
- NSPR $2.46
- WHWK $2.04
- Average True Range (ATR)
- NSPR 0.08
- WHWK 0.08
- MACD
- NSPR -0.00
- WHWK 0.03
- Stochastic Oscillator
- NSPR 23.53
- WHWK 85.29
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.